has been cited by the following article(s):
|
[1]
|
Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management
BioDrugs,
2022
DOI:10.1007/s40259-022-00536-8
|
|
|
|
|
[2]
|
To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives
Advanced Drug Delivery Reviews,
2022
DOI:10.1016/j.addr.2021.114079
|
|
|
|
|
[3]
|
To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives
Advanced Drug Delivery Reviews,
2022
DOI:10.1016/j.addr.2021.114079
|
|
|
|
|
[4]
|
To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives
Advanced Drug Delivery Reviews,
2022
DOI:10.1016/j.addr.2021.114079
|
|
|
|
|
[5]
|
Hemodynamic Effects on Particle Targeting in the Arterial Bifurcation for Different Magnet Positions
Molecules,
2019
DOI:10.3390/molecules24132509
|
|
|
|
|
[6]
|
Paradoxical rise of hemolytic complement in the blood of mice during zymosan- and liposome-induced CARPA: a pilot study
European Journal of Nanomedicine,
2015
DOI:10.1515/ejnm-2015-0022
|
|
|
|
|
[7]
|
Recommendations for Safety Pharmacology Evaluations of Oligonucleotide-Based Therapeutics
Nucleic Acid Therapeutics,
2014
DOI:10.1089/nat.2013.0477
|
|
|
|
|
[8]
|
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responses
Journal of Controlled Release,
2014
DOI:10.1016/j.jconrel.2014.08.009
|
|
|
|